Benefits
Supports Stomach Comfort
DGL has a long traditional use for supporting comfort after meals, helping ease occasional indigestion, fullness, and mild burning sensations associated with everyday dietary stressors.
Helps Maintain Gastric Mucosal Health
Licorice flavonoids may help maintain the protective mucus layer lining the stomach, supporting resilience of the gastric mucosa against everyday irritants. This is a laboratory and animal mechanism; the controlled trials cited here measured symptoms and ulcer healing, not the mucus layer itself.
Avoids Glycyrrhizin-Related BP Effects
Because glycyrrhizin has been largely removed, DGL is preferred over whole licorice for longer-term use, helping users obtain the soothing properties of the herb without the pseudo-aldosteronism risk of regular licorice.
May Ease Functional Dyspepsia Symptoms
One branded deglycyrrhizinated flavonoid extract, GutGard at 75 mg twice daily, produced greater reductions in dyspepsia symptom scores than placebo over 30 days, and a later placebo-controlled trial of the same extract found earlier easing of heartburn and regurgitation. That evidence belongs to the specific branded extract rather than to chewable DGL tablets, which did not outperform placebo for ulcer healing in the older trials.
Mechanism of action
Mucus Secretion and Mucosal Coating
Licorice flavonoids appear to increase secretion of mucin and stimulate prostaglandin-like cytoprotective pathways in the gastric epithelium, providing a physical and chemical barrier over irritated mucosa.
Anti-Inflammatory Flavonoid Activity
Glabridin, liquiritigenin, and related flavonoids inhibit pro-inflammatory NF-κB signaling and modulate cytokines such as TNF-α and IL-6 in gastrointestinal mucosa preclinically.
Helicobacter pylori Modulation
In vitro work and one randomized placebo-controlled trial of the branded GutGard extract, which tracked H. pylori stool antigen, suggest licorice flavonoids can suppress H. pylori adhesion and growth, which may contribute to the symptomatic relief seen in functional dyspepsia.
Clinical trials
Randomized, double-blind, placebo-controlled trial; 75 mg flavonoid-rich G. glabra extract twice daily for 30 days
Adults with functional dyspepsia (Rome criteria)
The branded extract GutGard was associated with significantly greater reductions in total symptom score and improvement in global efficacy assessment vs placebo, with good tolerability over the 30-day intervention.
Retrospective endoscopic survey; oral DGL tablets in patients with chronic duodenal ulcer
32 adult patients with endoscopically confirmed chronic duodenal ulcer
Endoscopic examination after a course of DGL showed ulcer healing in the surveyed group, with mucosa appearing largely normal at follow-up; an uncontrolled, non-randomized observation. The placebo-controlled trials of DGL came before it, in 1971 and 1973, and both found no advantage over placebo.
Double-blind randomized trial of DGL vs placebo in gastric ulcer patients
Adults with endoscopically documented gastric ulcer
No difference was found between DGL and placebo. There was no quicker healing in either group by change in ulcer area or by complete healing, and the authors concluded the study was not able to demonstrate any healing effect. A larger placebo-controlled trial in 96 gastric ulcer patients in 1978 also found no difference in healing, ulcer area or clinical improvement.